Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

US11090409B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11090409-B2
Application numberUS-201815982769-A
CountryUS
Kind codeB2
Filing dateMay 17, 2018
Priority dateApr 9, 2010
Publication dateAug 17, 2021
Grant dateAug 17, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

According to an illustrative embodiment a method to promote healing of a wound is provided comprising contacting the wound with a biologically active composition comprising a lipoic acid derivative and gelatin. In another embodiment a wound dressing is provided comprising a scaffold coated with a biologically active composition comprising a lipoic acid derivative. In a further embodiment, a system is provided for treating a tissue site of a patient, the system comprising a reduced-pressure source to supply reduced pressure, a manifold to distribute reduced pressure to a tissue site and a scaffold coated with a biologically active composition comprising a lipoic acid derivative. Methods for producing such a system and scaffold are also disclosed.

First claim

Opening claim text (preview).

We claim: 1. A reduced-pressure therapy system for treating a tissue site, comprising: a manifold at least partially coated with a composition comprising a gelatin substrate, a lipoic acid derivative, and a chelating agent, wherein the composition reduces excessive matrix metalloprotease activity, and wherein the lipoic acid derivative has the structure: wherein n 1 and n 2 are, independently, C 1 -C 10 alkyl; and R 1 is H, C 1 -C 10 alkyl, C 6 -C 14 aryl, an alkyl ammonium or a protonated amino acid; a drape adapted to provide a sealed space around the manifold and the tissue site; and a reduced-pressure source configured to deliver reduced pressure to the sealed space. 2. The system of claim 1 , further comprising a scaffold adapted to be positioned between the manifold and the tissue site, wherein the scaffold has a plurality of passages. 3. The system of claim 2 , wherein the scaffold comprises polyurethane or collagen. 4. The system of claim 2 , further comprising a release layer adapted to be positioned between the scaffold and the manifold. 5. The system of claim 1 , further comprising an interface for fluidly coupling the reduced-pressure source to the sealed space. 6. The system of claim 1 , wherein the lipoic acid derivative comprises alpha-lipoic acid or sodium lipoate. 7. The system of claim 1 , wherein the chelating agent comprises ethylenediaminetetraacetic acid. 8. The system of claim 1 , wherein the composition further comprises an antimicrobial agent, a growth factor, or a preservative. 9. The system of claim 8 , wherein the antimicrobial agent is non-ionic silver, polyhexamethylene biguanide, chlorhexidine, benzalconium chloride, or triclosan. 10. The system of claim 1 , wherein the composition further preserves granulation tissue. 11. The system of claim 1 , wherein the composition is formulated for time-controlled release of the lipoic acid derivative. 12. The system of claim 1 , wherein the composition comprises 0.1% to 25% w/w gelatin substrate. 13. The system of claim 1 , wherein the composition comprises a bloom value of between about 150-300 g. 14. The system of claim 1 , wherein the composition comprises a bloom value of between about 200-250 g. 15. The system of claim 1 , wherein the composition comprises a bloom value of about 225 g.

Assignees

Inventors

Classifications

  • with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants (for negative pressure wound therapy A61M1/92, A61M1/94; combined with tracheal tubes A61M16/0463; dental instruments with combined rinsing and aspirating A61C17/0208) · CPC title

  • with liquid supply means · CPC title

  • Constructional details of the pressure distribution manifold · CPC title

  • having five-membered rings · CPC title

  • Quaternary ammonium compounds, e.g. edrophonium, choline (betaines A61K31/205) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11090409B2 cover?
According to an illustrative embodiment a method to promote healing of a wound is provided comprising contacting the wound with a biologically active composition comprising a lipoic acid derivative and gelatin. In another embodiment a wound dressing is provided comprising a scaffold coated with a biologically active composition comprising a lipoic acid derivative. In a further embodiment, a sys…
Who is the assignee on this patent?
Kci Licensing Inc
What technology area does this patent fall under?
Primary CPC classification A61L26/0038. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).